AeroGen Inc (AEGN.OB)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

2071 STIERLIN COURT MOUNTAIN VIEW, CA 94043

AeroGen, Inc.'s principal activities are to develop, manufacture and market pulmonary drug delivery products. The products are used for the controlled delivery of drugs to the lungs. These include hand-held breath-activated inhalers and nebulizers for home and hospital use. The Group's first product is a Portable Nebulizer System marketed under the Aeroneb (R) brand name. Another product, Aerodose (R), allows for the treatment of diabetes by delivering insulin into the bloodstream through the lungs. The initial products of the Group will focus on treating three respiratory diseases, asthma, chronic obstructive pulmonary disease and cystic fibrosis. In addition to respiratory therapy activities, the Group intends to develop pulmonary drug delivery products for systemic drug delivery.

Data based on most recent fiscal year report
Market Cap19.757 Million Shares Outstanding26.88 Million Avg Volume134.069 Thousand
1-Yr BETA vs S&P TR Current Ratio2.36 Quick Ratio2.24

Are you looking for this stock instead?

View SEC Filings from AEGN.OB instead.

Funds Holding AEGN.OB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AEGN.OB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments